Faculty Disclosures - Relevant Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Commercial Support, The George Washington University School of Medicine and Health Sciences requires that all individuals involved in the development and presentation of CME activity content disclose any relevant financial relationships with commercial interest(s).
GW identifies and resolves all conflicts of interest prior to an individual’s participation in an educational activity.
The following faculty, planners, and staff report the following relevant financial relationships with commercial interest(s):




Randy Brand, MD              
Research Support: Immunovia
Grace Elta, MD                    
Consultant: Olympus Medical
Research Support: Merck
Catherine Frenette, MD    
Consultant: Bayer, Gilead, Conatus, Exelixis, Eisai, Merck, Genentech
Speaker's Bureau: Bristol Meyers Squibb, Abbvie, Intercept, Salix, Gilead, Exelixis, Eisai, Merck, Genentech
Colin Howden, MD              
Consultant: Ironwood, RedHill, Phathom
Stock Owner: Antibe
Douglas Rex, MD                
Consultant: Olympus, Braintree Laboratories, GI Supply, Endokey
Research Support: Braintree Laboratories
Mitchell Shiffman, MD       
Consultant: Abbvie, Gilead, Intercept
Research Support: Intercept, Genfit, Gilead, CymaBay                                         
Speaker's Bureau: Abbvie, Gilead, Intercept                                                                                                                                                                                       
Stuart Spechler, MD             
Consultant: Phathom Pharmaceuticals, Interpace Diagnostics, Ironwood Pharmaceuticals